4.3 Article

Sauti ya Vijana (SYV; The Voice of Youth): Longitudinal Outcomes of an Individually Randomized Group Treatment Pilot Trial for Young People Living with HIV in Tanzania

Journal

AIDS AND BEHAVIOR
Volume 26, Issue 6, Pages 2015-2025

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10461-021-03550-z

Keywords

Mental health; HIV; Adolescent; Africa; Tanzania

Funding

  1. NIH [P30 AI064518]
  2. International Research Scientist Development Award - Fogarty International Center
  3. National Institute of Mental Health [K01 TW-009985, R25 TW009337]
  4. Fogarty International Center
  5. Center for AIDS Research (CFAR), Duke University
  6. CTSA grant [UL1TR002553]

Ask authors/readers for more resources

Sauti ya Vijana is a mental health and life skills intervention for young people living with HIV in Tanzania. The pilot trial suggests that this intervention holds promise in improving antiretroviral therapy adherence and virologic suppression in young people, but further research is needed to confirm these findings.
Sauti ya Vijana is a mental health and life skills intervention delivered by young adult group leaders for the improvement of HIV outcomes in young people living with HIV in Tanzania. This pilot randomized controlled trial estimated exploratory intervention effectiveness compared to standard of care. YPLWH (N = 105) were randomized to receive intervention or SOC. The mean age of participants was 18.1 years and 53% were female. Mean scores on mental health measures (Patient Health Questionnaire [PHQ-9], Strengths and Difficulties Questionnaire [SDQ], UCLA Trauma) were asymptomatic to mild in both study arms through 30-month follow-up with a non-significant fluctuation of 1-2 points. The mean self-reported adherence was higher in the intervention arm across all time points (but the confidence interval contained the null at all time points except 6 months). Risk ratio of virologic suppression (HIV RNA < 400 copies/mL) in the intervention arm compared to SOC was 1.15 [95% CI = 0.95, 1.39]) at 6-months, 1.17 [95% CI: 0.92, 1.48] at 12-months, and 0.99 [95% CI 0.76, 1.31] at 18-months. Though these findings were not powered for statistical significance, the trends in HIV outcomes suggest that SYV holds promise for improving antiretroviral therapy (ART) adherence and virologic suppression in YPLWH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available